期刊文献+

改良培养法对提高老年多发性骨髓瘤患者染色体异常克隆检出率的研究 被引量:2

Effect of a modified culture method on detection rate of karyotype anomalies in elderly patients with multiple myeloma
原文传递
导出
摘要 目的评价改良培养方法在老年多发性骨髓瘤(multiplemyeloma,MM)患者中能否提高染色体异常克隆的检出率,同时探讨染色体核型异常与老年MM患者临床特征的关系。方法取我院2011年1月至2012年6月28例MM患者的骨髓标本,同时以常规24h短期培养法和改良6d长期培养法,培养基中添加白介素6(interleukin6,II。一6)10,ug/L和粒一单细胞刺激因子(granulocyte—macrophagecolony-stimulatingfactor,GM—CSF)40/,g/L。然后采用G显带法进行染色体核型分析。结果28例行常规24h短期培养法组中,4例患者未见分裂相,检测失败率14.3%;有分裂相的24例患者中,6例发现核型异常,染色体异常克隆检出率为25.0%。改良6d长期培养组中,28例中仅1例患者未见分裂相,检测失败率3.6%;27例有分裂相的患者中,15例检出有异常克隆存在,异常克隆检出率55.6%,两组染色体异常克隆检出率差异有统计学意义(x2=4.89,p〈0.05)。在可供分析的27例患者中,20例为初诊或进展期患者,7例为疾病稳定期的患者,初诊或进展期患者染色体异常克隆检出率为70.0%(14/20),稳定期的患者染色体异常克隆检出率为14.3%(1/7),前者染色体异常克隆检出率高于后者,经Fisher精确检验P〈0.05。结论6d改良培养法可提高老年多发性骨髓瘤患者染色体异常克隆检出率,优于24h常规培养法。初诊、进展期患者的染色体异常克隆检出率高于稳定期患者。 Objective To evaluate the effect of a modified culture method on the karyotype anomalies detection rate in elderly patients with multiple myeloma (MM), and to explore the relationship between clinical characteristics and chromosome anomalies in multiple myeloma. Methods Two culture methods were applied on the bone marrow samples which obtained from 28 MM patients. One method was used to culture cells for 24 hours with interleukin 6 (IL-6) 10 ptg/L and granulocyte-macrophage colony-stimulating factor (GM-CSF) 40 /,g/L, and the other for 6 days. Karyotype was analyzed by G-banding technique. Results In the 24-hour culture group, no metaphases cell was found in 4 cases (14.3 ~/00 ), karyotype anomalies were found in 6 cases in the other 24 cases, and the detection rate was 25.0% (6/24). In the 6-day culture group, no metaphases cell was found in 1 patient (3.6G), karyotype anomalies were found in 15 cases in the other 27 patients, and the detection rate was 55.6~ (15/27). There was a significant difference in the detection rate of karyotype anomalies between the two groups (Z2 = 4.89, P (0.05). In 27 cases with enough metaphases in the 6 day culture group, 20 cases were newly diagnosed or in progression, among whom karyotype anomalies were found in 14 cases (70.0~//0, 14/20), and 7 cases were in stable phase, among whom karyotype anomalies were found in 1 case (14.30%, 1/7). The detection rate of abnormal karyotype was higher in newly diagnosed or in progressive patients than in stable patients (P 〈0.05). Conclusions 6-day culture method can improve the detection rate of karyotype anomalies in elderly patients with multiple myeloma, which is better than 24-hour culture method. The detection rate of karyotype anomalies is higher in newly diagnosed or in progressive patients than in stable patients.
出处 《中华老年医学杂志》 CAS CSCD 北大核心 2013年第12期1312-1315,共4页 Chinese Journal of Geriatrics
关键词 多发性骨髓瘤 染色体显带 细胞培养技术 Multiple myeloma Chromosome banding Cell culture techniques
  • 相关文献

参考文献7

  • 1Robert K, Morie G,Thomas W, et al, Review o{ 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc,2003 ,78 : 21 33 .
  • 2岑岭,周民,陈涛,肖溶,杨建和,姜乃可,章艳.老年与非老年组多发性骨髓瘤的临床细胞遗传学和预后的比较[J].中华医学遗传学杂志,2010,27(6):710-711. 被引量:5
  • 3Heinrich PC,Behrmann I, Haan S, et al. Principles of interleukin (IL) -6-type cytokine signaling and its regulation. Biochem J, 2003, 374:1-20.
  • 4Nilsson T,Lenhoff S, Turesson I, et al. Cytogenetic features of multiple myeloma: impact of gender, age, disease phase, culture time, and cytokine stimulation. Eur J Haematol, 2002 ,68..345-353.
  • 5张艳,江滨,黄晓军,师岩,何琦,党辉,邱镜滢,陆道培.多发性骨髓瘤的细胞遗传学研究[J].中国实验血液学杂志,2007,15(1):76-78. 被引量:20
  • 6FaconT, Lai JL, Natal" E, et al . Improved cytogenetic analysis of bone marrow plasma cells after cytokine stimulation in multiple myeloma: a report on 46 patients. BrJ Haematol, 1993,84:743-745.
  • 7Debes-Marum CS, Dewald GW, Bryant S, et al. Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myeloma. Leukemia, 2003,17:427-436.

二级参考文献15

  • 1麦玉洁,邱录贵,李睿,靳风艳,白洁,万长春,王建祥,季林祥,肖志坚,钱林生.432例多发性骨髓瘤临床分析[J].白血病.淋巴瘤,2004,13(4):198-201. 被引量:27
  • 2Robert K,Morie G,Thomas W,et al.Review of 1027 patients with newly diagnosed multiple myeloma.Mayo Clin Proc,2003,78:21-23.
  • 3张之甫.血液病诊断及疗效标准.第3版.北京:北京科学技术出版杜,2007.232-235.
  • 4ISCN(2009):An International System for Human Cgtogenetic Nomenclature.Miteltnan F.S.Karger,Basel,2009.
  • 5Zhan F,Sawyer J,Tricot G.The role of cytogenetics in myeloma.Leukemia,2006,20:1481-1486.
  • 6Debes-Marum CS, Dewald GW, Bryant S, et al. Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myeloma. Leukemia, 2003 ; 17:427 - 436
  • 7Lai JL, Zandecki M, Mary JY, et al. Improved cytogenetics in multiple myeloma:a study of 151 patients including 117 patients at diagnosis. Blood, 1995 ; 85:2490 - 2497
  • 8Harrison C J, Mazzullo H, Cheung KL, et al. Cytogenetics of multiple myeloma:interpretation of fluorescence in situ hybridization resuits. Br J Haematol, 2003; 120:944 -952
  • 9Avet-Loiseau H, Facon T, Grosbois B, et al. Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentation. Blood, 2002; 99:2185-2191
  • 10Zojer N, Konigskerg R, Ackermann J, etal. Deletion of 13q14 remains an independent adverse prognostic variable in multiple myeloma despite its frequent detection by interphase fluorescence in situ hybridization. Blood, 2000; 95: 1925- 1930

共引文献23

同被引文献10

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部